Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

1606 (CBDW) EBIT (2021 - 2025)

1606 (CBDW) has disclosed EBIT for 5 consecutive years, with -$111446.0 as the latest value for Q3 2025.

  • On a quarterly basis, EBIT rose 96.57% to -$111446.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$608080.0, a 85.66% increase, with the full-year FY2024 number at -$4.1 million, down 155.45% from a year prior.
  • EBIT was -$111446.0 for Q3 2025 at 1606, up from -$117084.0 in the prior quarter.
  • In the past five years, EBIT ranged from a high of -$14701.0 in Q1 2021 to a low of -$3.2 million in Q3 2024.
  • A 5-year average of -$368542.5 and a median of -$153697.0 in 2022 define the central range for EBIT.
  • Peak YoY movement for EBIT: plummeted 891.54% in 2022, then surged 96.57% in 2025.
  • 1606's EBIT stood at -$97205.0 in 2021, then tumbled by 58.12% to -$153697.0 in 2022, then plummeted by 99.24% to -$306230.0 in 2023, then skyrocketed by 32.95% to -$205318.0 in 2024, then skyrocketed by 45.72% to -$111446.0 in 2025.
  • Per Business Quant, the three most recent readings for CBDW's EBIT are -$111446.0 (Q3 2025), -$117084.0 (Q2 2025), and -$174232.0 (Q1 2025).